21416219

Source:http://linkedlifedata.com/resource/pubmed/id/21416219

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020557, umls-concept:C0030705, umls-concept:C0060179, umls-concept:C0087111, umls-concept:C0205322, umls-concept:C0360714, umls-concept:C0443252, umls-concept:C1709056
pubmed:issue	1
pubmed:dateCreated	2011-4-4
pubmed:abstractText	The objective of this study was to evaluate the long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients at goal for low-density lipoprotein cholesterol (LDL-C) but with persistent hypertriglyceridemia.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-11996956, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-12240789, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-12427645, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-14516878, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-15023300, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-1519522, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-15249516, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-1543692, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-15670545, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-16098311, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-16157765, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-1728471, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-17357251, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-17398308, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-17483155, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-18036028, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-18402913, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-18422390, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-18996523, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-19081418, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-19195513, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-21291776, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-8060384, http://linkedlifedata.com/resource/pubmed/commentcorrection/21416219-8836866
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8712220
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate, http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes, http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin, http://linkedlifedata.com/resource/pubmed/chemical/fenofibric acid, http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1573-7241
pubmed:author	pubmed-author:BallantyneChristie MCM, pubmed-author:JonesPeter HPH, pubmed-author:KellyMaureen TMT, pubmed-author:LeleAdityaA, pubmed-author:SetzeCarolyn MCM, pubmed-author:StolzenbachJames CJC, pubmed-author:ThakkerKamlesh MKM
pubmed:issnType	Electronic
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	59-67
pubmed:meshHeading	pubmed-meshheading:21416219-Anticholesteremic Agents, pubmed-meshheading:21416219-Apolipoproteins B, pubmed-meshheading:21416219-Cholesterol, LDL, pubmed-meshheading:21416219-Double-Blind Method, pubmed-meshheading:21416219-Drug Interactions, pubmed-meshheading:21416219-Drug Therapy, Combination, pubmed-meshheading:21416219-Female, pubmed-meshheading:21416219-Fenofibrate, pubmed-meshheading:21416219-Fluorobenzenes, pubmed-meshheading:21416219-Heptanoic Acids, pubmed-meshheading:21416219-Humans, pubmed-meshheading:21416219-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:21416219-Hypertriglyceridemia, pubmed-meshheading:21416219-Male, pubmed-meshheading:21416219-Middle Aged, pubmed-meshheading:21416219-Pyrimidines, pubmed-meshheading:21416219-Pyrroles, pubmed-meshheading:21416219-Simvastatin, pubmed-meshheading:21416219-Sulfonamides, pubmed-meshheading:21416219-Triglycerides
pubmed:year	2011
pubmed:articleTitle	Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
pubmed:affiliation	Baylor College of Medicine, Methodist DeBakey Heart and Vascular Center, Houston, TX 77030, USA. cmb@bcm.tmc.edu
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III